Polymyxins are a class of last-resort antibiotics used to treat infections caused by multidrug-resistant bacteria. Mobile resistance determinants for polymyxins, including mcr-1 to mcr-10 genes, have previously been r...
grateful for the financial supports from the National Key R&D Program of China(2018YFA0902200);the National Natural Science Foundation of China(Program:21878224).
Polymyxin B,produced by Paenibacillus polymyxa,is used as the last line of defense clinically.In this study,exogenous mixture of precursor amino acids increased the level and proportion of polymyxin B1 in the total of...
funds provided by African German Network of Excellence in Science 2022 (AGNES-2022).
Resistance/sensitivity to polymyxin-B(PB)antibiotic has been employed as one among other epidemiologically relevant biotyping-scheme for Vibrio cholerae into Classical/El Tor biotypes.However,recent studies have re-ve...
supported by the National Natural Science Foundation of China(32141003);the CAMS Innovation Fund for Medical Sciences(CIFMS)(2021-I2M-1-030,2021-I2M-1-039,China);the Fundamental Research Funds for the Central Universities(2021-PT350-001,China);the National Science and Technology Infrastructure of China(NPRC-32)。
Polymyxin B and polymyxin E(colistin)are presently considered the last line of defense against human infections caused by multidrug-resistant Gram-negative organisms such as carbapenemase-producer Enterobacterales,Aci...
supported by the National Natural Science Foundation of China(82070228,81773283);the National Key R&D Program of China(No.2019YFC1316204)。
Chronic inflammation is critical in the onset and progression of atherosclerosis(AS).The lipopolysaccharide(LPS)level in the circulation system is elevated in AS patients and animal models,which is correlated with the...
Supported by The Hunan Province Natural Science Foundation,No.2022JJ80043;Nature Science Foundation of Changsha,No.kq2014268;Hunan Engineering Research Center of Intelligent Prevention and Control for Drug Induced Organ Injury,No.40;Scientific Research Fund Project of Hunan Pharmaceutical Society,No.2020YXH010.
BACKGROUND Polymyxin-induced nephrotoxicity is a major safety concern in clinical practice due to long-term adverse outcomes and high mortality.AIM To conducted a systematic review and meta-analysis of the prevalence ...
supported by the National Key Research and Development Program of China (2017YFC1600100 and2017YFC1200203);the National Natural Science Foundation of China (81702040);the National Science Foundation of Zhejiang Province,China (LY20H190002)
Humanity is facing an enormous and growing worldwide threat from the emergence of multi-drug-resistant(MDR)Gram-negative bacteria such as Escherichia coli,Klebsiella pneumoniae,and Acinetobacter baumannii.Polymyxin B ...
the National Key Research&Development Program(2018YFC1200100,2018YFC1200105);the Major Research and Development Project of Innovative Drugs,Ministry of Science and Technology of China(2017ZX09304005).
The polymyxins are important antimicrobial agents against antibiotic-resistant gram-negative bacilli.In 2020,the Clinical and Laboratory Standards Institute modified the clinical breakpoints for polymyxin susceptibili...
This study was supported by a grant from Education of Zhejiang Province Y201737787(JY)];National Natural Science Foundation of China 81901989(DML);Project funded by China Postdoctoral Science Foundation 2019M652108(DML).
Background Increased meningitis caused by extensively drug-resistant bacillary presents a significant challenge in antibiotic selection.The aim of our study was to evaluate the efficacy and safety of polymyxin in the ...